Text Size
15 studies found for:    "NJMS" OR "New Jersey Medical School" | Open Studies | "Retroviridae Infections"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide;   Drug: elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate
2 Recruiting Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: elvitegravir/cobicistat/emtricitabine/tenofovir df;   Drug: ritonavir + atazanavir + emtricitabine/tenofovir df
3 Available An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection
Condition: HIV Infection
Intervention: Drug: Efavirenz
4 Unknown † Longitudinal Study of Ocular Complications of AIDS (LSOCA)
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Cytomegalovirus Retinitis
Intervention: Drug: Highly Active Anti-Retroviral Therapy (HAART)
5 Recruiting Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Conditions: HIV Infections;   Pregnancy Complications, Infectious
Intervention: Behavioral: Adherence assessment
6 Recruiting Strategic Timing of Antiretroviral Treatment
Condition: HIV Infection
Intervention: Drug: All licensed antiretroviral medications
7 Recruiting Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults
Condition: HIV Infections
Interventions: Drug: Raltegravir (RAL);   Drug: Atazanavir (ATV);   Drug: Ritonavir (RTV);   Drug: Tenofovir (TDF);   Drug: Etravirine (ETV);   Drug: Darunavir (DRV);   Drug: Maraviroc (MVC);   Drug: Lopinavir/ritonavir (LPV/r)
8 Recruiting Long-Term Outcomes in HIV-Infected Infants, Children, and Adolescents
Condition: HIV Infections
Intervention:
9 Recruiting Consent for Use of Stored Patient Specimens for Future Testing
Condition: HIV Infections
Intervention:
10 Recruiting Evaluating the Safety and Effectiveness of Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Conditions: Tuberculosis;   HIV Infections
Interventions: Drug: Rifapentine (RPT);   Drug: Isoniazid (INH);   Dietary Supplement: Pyridoxine (Vitamin B6)
11 Recruiting Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in Men Who Have Sex With Men and in At-Risk Women
Condition: HIV Infection
Interventions: Drug: Maraviroc;   Drug: Emtricitabine;   Drug: Tenofovir disoproxil fumarate;   Other: Maraviroc placebo;   Other: Emtricitabine placebo;   Other: Tenofovir disoproxil fumarate placebo
12 Recruiting Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Pegylated-Interferon Alfa 2b (PEG-IFN);   Drug: Ribavirin (RBV);   Drug: Boceprevir (BOC)
13 Recruiting Evaluating the Effectiveness of the Quadrivalent Human Papillomavirus (HPV) Vaccine at Preventing Anal HPV Infection in HIV-Infected Men and Women
Condition: HIV Infections
Interventions: Biological: Quadrivalent HPV Vaccine;   Biological: Placebo Vaccine for Male Participants Only;   Biological: Placebo Vaccine for Female Participants Only
14 Recruiting Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
Condition: HIV-1 Infection
Interventions: Drug: Darunavir;   Drug: Ritonavir;   Drug: Tenofovir disoproxil fumarate;   Drug: Emtricitabine;   Drug: Placebo for Tenofovir disoproxil fumarate;   Drug: Placebo for Maraviroc
15 Recruiting Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
Condition: HIV-1 Infection
Intervention: Drug: atorvastatin
To Top

† Indicates status has not been verified in more than two years